A new study co-authored by Dr. Hari Iyer and colleagues examines the relationship between per- and polyfluoroalkyl substances (PFAS) in drinking water and cancer prevalence across the United States. Using … Read More
A study co-authored by Dr. Hari Iyer and colleagues, published in Cancer Medicine, finds that climate-related natural disasters may be associated with increased mortality among men with metastatic prostate cancer. … Read More
A new study co-authored by Dr. Hari Iyer and colleagues examines the relationship between per- and polyfluoroalkyl substances (PFAS) in drinking water and cancer prevalence across the United States. Using … Read More
Prostate cancer is one of the most common cancers among men in the United States, and today, more than three million men are living as prostate cancer survivors. Advances in … Read More
Our team contributed to a new cross-sectional analysis of more than 3,100 U.S. counties, which examined how breast, cervical, and colorectal cancer screening rates have changed over the past two … Read More
The Pre2 CaP Lab is getting ready for another busy year! Some research and publication highlights from the past few months: Agent Orange and Prostate Cancer in Veterans Dr. Iyer … Read More
Prostate-specific antigen (PSA) screening for prostate cancer remains controversial due to lack of consistent survival benefits reported from clinical trials, and concerns about harms associated with overtreatment. However, it is … Read More
Our team recently published an article using registry cohort to examine whether county-level prevalence of prostate-specific antigen (PSA) screening was associated with lower odds of advanced stage prostate cancer, and … Read More
The Pre2 CAP laboratory recently coauthored a study published in JAMA Network Open in partnership with the US Veterans Health Administration comparing the magnitude of racial and socioeconomic disparities among … Read More